美国OTC市场Tc Biopharm (Holdings) Plc股价上涨22.73% 市值涨6.46万美元

市场透视12-01

北京时间2025年12月01日23时14分，美国OTC市场Tc Biopharm (Holdings) Plc（TCBPY.us）股票出现异动，股价急速拉升22.73%。截至发稿，该股报0.135美元/股，成交量2.3464万股，换手率1.12%，振幅0.91%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.53百万美元，每股收益-164.58美元，毛利-554914.27美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588035907?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-01 23:14","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2588035907","market":"us","top_or_hot":-1,"title":"美国OTC市场Tc Biopharm (Holdings) Plc股价上涨22.73% 市值涨6.46万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年12月01日23时14分，美国OTC市场Tc Biopharm (Holdings) Plc（TCBPY.us）股票出现异动，股价急速拉升22.73%。截至发稿，该股报0.135美元/股，成交量2.3464万股，换手率1.12%，振幅0.91%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.53百万美元，每股收益-164.58美元，毛利-554914.27美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201231401a4c61288&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场Tc Biopharm (Holdings) Plc股价上涨22.73% 市值涨6.46万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场Tc Biopharm (Holdings) Plc股价上涨22.73% 市值涨6.46万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-01 23:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201231401a4c61288&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年12月01日23时14分，美国OTC市场Tc Biopharm (Holdings) Plc（TCBPY.us）股票出现异动，股价急速拉升22.73%。截至发稿，该股报0.135美元/股，成交量2.3464万股，换手率1.12%，振幅0.91%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.53百万美元，每股收益-164.58美元，毛利-554914.27美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201231401a4c61288&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201231401a4c61288&s=b","article_id":"2588035907","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201231401a4c61288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588035907","pubTimestamp":1764602041,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年12月01日23时14分，美国OTC市场Tc Biopharm  Plc股票出现异动，股价急速拉升22.73%。截至发稿，该股报0.135美元/股，成交量2.3464万股，换手率1.12%，振幅0.91%。美国OTC市场Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为1.10%。美国OTC市场Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","TCBPY":"TC BioPharm (Holdings) plc"},"translate_title":"Tc Biopharm (Holdings) Plc shares rose 22.73% in the U.S. OTC market, and its market value rose by US $64,600","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCBPY":0.9},"content_text":"北京时间2025年12月01日23时14分，美国OTC市场Tc Biopharm (Holdings) Plc（TCBPY.us）股票出现异动，股价急速拉升22.73%。截至发稿，该股报0.135美元/股，成交量2.3464万股，换手率1.12%，振幅0.91%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.53百万美元，每股收益-164.58美元，毛利-554914.27美元，市盈率-0.00倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Tc Biopharm (Holdings) Plc股票所在的生物技术行业中，整体跌幅为1.10%。其相关个股中，Q32 Bio Inc.、Kala Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃，换手率分别为922.95%、793.35%、69.04%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Q32 Bio Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)，振幅分别为101.36%、100.45%、64.00%。美国OTC市场Tc Biopharm (Holdings) Plc公司简介：TC BioPharm (Holdings) PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T（缩写为 GD-T）细胞平台的新型免疫治疗产品。 利用 GD-T 的先天能力，该公司能够开发出一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588035907","isCrawlerRequest":true}